期刊文献+

脑胶质瘤组织中核干细胞因子的表达 被引量:4

下载PDF
导出
摘要 胶质瘤亦称神经胶质细胞瘤,起源于神经上皮细胞,是一种常见的颅内恶性肿瘤,具有高发病率、高复发率、高死亡率及低治愈率的"三高一低"的特点。核干细胞因子(nucleostemin,NS)是一个细胞核内的鸟嘌呤核苷酸结合蛋白,定位于干细胞和肿瘤细胞的细胞核,参与干细胞和肿瘤细胞的增殖调控。目前已有研究,显示,在多种癌组织中均有NS的高表达。作者观察了NS蛋白在脑胶质瘤组织中的表达情况,报道如下。
出处 《郑州大学学报(医学版)》 CAS 北大核心 2013年第4期559-560,共2页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省科技攻关计划基金资助项目102300410065
  • 相关文献

参考文献7

  • 1Tsai RY, McKay RD. A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells [ J ]. Gene Dev,2002,16(23 ) :2991.
  • 2蔡子微,郑学芝,胡静.乳腺肿瘤组织nucleostemin基因表达与临床病理表现的关系[J].中国病理生理杂志,2007,23(11):2191-2194. 被引量:13
  • 3Liu SJ, Gai ZW, Liu YJ, et al. Role of nuelenstemin in growth regulation of gastric cancer,liver c, ancer and other malignancies[ J ]. World J Gastroenterol, 2004, 10 ( 9 ) : 1246.
  • 4Singh SK, Hawkin S, Clarke 1D, et al. Identification of hu- man brain tumour initiating cells [ J ] Nature, 2004,432 (7015) :396.
  • 5Ricei-Vitiani L,Lombardi DG, Pilozzi E,et al. ldenticica- tion and expansion of human colon cancer initiating cells [J]. Nature,2007,445(7123):lll.
  • 6Godschmidt-Clermont PJ. Loss of bone lraarrow-derived vas- cular progenitor cells lead to inflammation and atheroscle- rosis [ J ]. Am Hear J,2003,146(4 Suppl) :S5.
  • 7Liu SJ, Cai ZW, Liu YJ, et al. The effect of knocking-down nucleostemin gene expression on the in vitro proliferation and in vivo tumorigenesis of HeLa cells [ J]. J Exp Clin Cancer Res, 2004,23 ( 3 ) :529.

二级参考文献4

共引文献12

同被引文献34

  • 1谷建琦,张英怀,杨威,张杰英,蒋崇槟,贾志宇.脆性组氨酸三聚体基因及错配修复基因hMLH_1在口腔鳞状细胞癌中的表达及意义[J].第三军医大学学报,2007,29(2):151-153. 被引量:7
  • 2Sugiyama N,Gucciardo E,Lehti K. EphA2 bears plasticity to tumor invasion[J].CELL CYCLE,2013,(18):2927-2928.
  • 3Sugiyama N,Gucciardo E,Tatti O. EphA2 cleavage by MT1-MMP triggers single cancer cell invasion via homotypic cell repulsion[J].Cell Bio1,2013,(03):467-484.
  • 4Louis DN,Ohgaki H,Otmar D. The 2007 WHO Classification of tumours of the central nervous system[J].Acta Neuropathologica,2007,(02):97-109.
  • 5Blevins KS,Jeong JH,Ou M. EphA2 targeting peptide tethered bioreducible poly(cystamine bisacrylamide-diamino hexane) for the delivery of therapeutic pCMV-RAE-1 gamma to pancreatic islets[J].Journal of Controlled Release,2012,(01):115-122.
  • 6Thundyil J,Manzanero S,Pavlovski D. Evidence that the EphA2 receptor exacerbates ischemic brain injury[J].PLoS One,2013,(01):e53528.
  • 7Tognolini M,Giorgio C,Mohamed IH. Perturbation of the EphA2EphrinA1 system in human prostate cancer cells by colonic (Poly) phenol catabolites[J].Journal of Agricultural and Food Chemistry,2012,(03):8877-8884.
  • 8Zhou N,Zhao WD,Liu DX. Inactivation of EphA2 promotes tight junction formation and impairs angiogenesis in brain endothelial cells[J].Microvascular Research,2011,(07):113-121.
  • 9Russo S,Incerti M,Tognolini M. Synthesis and structure-activity relationships of amino acid conjugates of cholanic acid as antagonists of the EphA2 receptor[J].MOLECULES,2013,(10):13043-13060.
  • 10Chen HJ,Yuan BA,Zheng ZC. A novel vaccine containing EphA2 epitope and LIGHT plasmid induces robust cellular immunity against glioma U251 cells[J].CELLULAR IMMUNOLOGY,2011,(01):102-106.

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部